Applying the herpes simplex virus thymidine kinase/ganciclovir approach to ovarian cancer: An effective in vitro drug-sensitization system

Gynecologic and Obstetric Investigation

Volumn 43, Issue 4, 1997, Pages 268-275

  Al Hendy, Ayinan ^a   Auersperg, Nelly ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adenovirus; Ganciclovir; Gene therapy; Ovarian cancer; Thymidine kinase

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CELL KILLING; CONTROLLED STUDY; EPITHELIUM CELL; EXPRESSION VECTOR; FEMALE; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

EID: 0031010299     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291870     Document Type: Article

References (22)

1. Boring C, Squires T. Tony T. Montgomery S: Cancer statistics. Cancer 1994:44:7-26.
2. NIH Consensus Statement: Ovarian Cancer: Screening, Treatment, and Follow-Up. Bethes-da. NIH, 1994, vol 12, No.3, pp 1-30.
3. McGuire WP, Hoskins WJ, Brady MF. Kugera PR, Partridge EE, Look KY, Clarke-Pearson DL. Davidson M: Cyclophosphamide and cis-platin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer. N Engl J Med 1996:334:1-6.
4. Richardson GS, Scully RE, Nikrui N, Nelson HJ Jr: Common epithelial cancer of the ovary. N Engl J Med 1985:312:415-424.
5. Harris JD, Gutierrez AA, Hurst HC, et al: Gene therapy for cancer using tumour-specific prodrug activation. Gene Ther 1994; 1:1 TOWS.
6. Mattews T, Bochmc R: Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988; 10(suppl):490-494.
7. Freeman SM. Abboud CN. Whartqnby KA. Packman CH. Koeplin DS. Moolten FL. Abraham GN: The ‘bystander effect’: Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993:53:5274-5283.
8. Culver KW. Ram Z, Wallbridge N, Ishii H, Oldfield EH, Blease RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992;256:1550-1552.
9. Kozarsky KF. Wilson JM: Gene therapy: Adenovirus vectors. Curr Opin Genet Dev 1993:3: 499-503.
10. Chen S-H. Chen XH. Wang Y, Kosai K-I. Fine-gold MJ. Rich SS, Woo SLC: Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sei USA 1995: 92:2577-2581.
11. Smythe WR, Hwang HC, Amin KM. Eck SL, Davidson BL. Wilson JM. Kaiser LR, Albclda SM: Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase gene to thoracic neoplasm: An effective in vitro drug sensitization system. Cancer Res 1994:54: 2055-2059.
12. Smythe WR. Hwang HC. Elshami AA, Amin KM, Eck SL. Davidson BL, Wilson JM, Kaiser LR, Albclda SM: Treatment of experimental human mesothelioma using adenovirus transféré of the herpes simplex thymidine kinase gene. Ann Surg 1995:222:78-86.
13. Chen S-H. Shine HD. Goodman JC. Grossman RG, Woo SLC: Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sei USA 1994;91:3054-3057.
14. O’Malley BW, Chen S-H, Schwartz MR, Woo SLC: Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 1995:55: 1080-1085.
15. Hamilton TC, Young RC. Mckoy WM, Grot-zinger KR, Green JA, Chu EW, Whang-Peng J. Rogan AM. Green WR, Ozols RF: Characterization of a human ovarian carcinoma line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 1983:43:5379-5389.
16. Fogh J. Trempe G: New tumor cell lines; in Fogh J (ed): Human Tumor Cells in vitro. New York, Plenum Press, 1975. pp 55-159.
17. Kruk PA, Maines-Bandiera SL, Auersperg N: A simplified method to culture human ovarian surface epithelium. Lab Invest 1990:63:132-136.
18. Stratford-Perricaudet LD, Makeh I. Perricau-det M, Brand P: Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992:90:626-630.
19. Alley MC. Scudiero DA. Monks A, Hursey ML, Czerwinski MJ. Fine LF: Feasibility of drug screening w ith panels ofhuntan tumor cell lines using a microculture tétrazolium assay. Cancer Res 1988:48:589-601.
20. ACOG Committee Opinion: Second-Look Laparotomy for Epithelial Ovarian Cancer. Washington, DC. ACOG Committee. 1995, No. 165, pp 1-4.
21. Barba D, Hardin J, Sadelain M, Gage FH: Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 1994;91:4348-4352.
22. Paul S, Dummer S: Topics in clinical pharmacology: Ganciclovir. Am J Med Sci 1992:4: 272-277.